MSL
EGRX

Mackay Shields LLC’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Mackay Shields LLC’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-6,371
Closed -$336K – 1316
2018
Q1 		$336K Buy
+6,371
New +$336K ﹤0.01% 1172